MyAverix Finance MyAverix Finance

TA · Healthcare

Cannassure Therapeutics Ltd (CSURE)

Healthcare Providers & Services

Cannassure Therapeutics Ltd (CSURE) is listed on TA in the Healthcare sector. Industry: Healthcare Providers & Services. As of 2026-05-24, reported P/E ratio is 22.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for CSURE

P/E ratio
22.00

Cannassure Therapeutics Ltd (CSURE) — FAQ

What is CSURE's P/E ratio?

The price-to-earnings (P/E) ratio for Cannassure Therapeutics Ltd (CSURE) is 22.00 (data as of 2026-05-24).

Does Cannassure Therapeutics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Cannassure Therapeutics Ltd (CSURE). Check the MyAverix Finance app for the latest dividend data.

What sector is Cannassure Therapeutics Ltd in?

Cannassure Therapeutics Ltd (CSURE) is classified in the Healthcare sector (Healthcare Providers & Services industry).

What exchange is CSURE listed on?

CSURE is listed on TA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play